This bill aims to enhance awareness of renal medullary carcinoma (RMC) among individuals with sickle cell disease who are enrolled in Medicaid . It seeks to achieve this by providing financial incentives to states for offering educational services related to RMC risk. Specifically, the legislation amends Section 1903(a)(3)(E)(ii) of the Social Security Act, which governs federal medical assistance percentages. By inserting "renal medullary carcinoma" into the existing text, the bill ensures that states can receive enhanced federal matching funds for expenditures related to educating Medicaid beneficiaries with sickle cell disease about the risks of RMC. This change is intended to promote early detection and improved health outcomes for this vulnerable population.
Byron Nash Renal Medullary Carcinoma Awareness Act of 2019
Introduced in House
Referred to the House Committee on Energy and Commerce.
Health
CancerDigestive and metabolic diseasesHealth promotion and preventive careMedicaid
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
USA119th CongressHR-124| House
| Updated: 1/3/2025
This bill aims to enhance awareness of renal medullary carcinoma (RMC) among individuals with sickle cell disease who are enrolled in Medicaid . It seeks to achieve this by providing financial incentives to states for offering educational services related to RMC risk. Specifically, the legislation amends Section 1903(a)(3)(E)(ii) of the Social Security Act, which governs federal medical assistance percentages. By inserting "renal medullary carcinoma" into the existing text, the bill ensures that states can receive enhanced federal matching funds for expenditures related to educating Medicaid beneficiaries with sickle cell disease about the risks of RMC. This change is intended to promote early detection and improved health outcomes for this vulnerable population.